Dr. Michael A. Caligiuri MD Medical Oncologist

Dr. Michael Caligiuri is a medical oncologist in Columbus, Ohio and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Hospital. He received his medical degree from Stanford University School of Medicine and has been in practice for 31 years. Dr. Caligiuri accepts several types of health insurance, listed below. He is one of 21 doctors at James Cancer Hospital and Solove Research Institute and one of 17 at Ohio State University Hospital who specialize in Medical Oncology.

Are you Dr. Caligiuri? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Ohio State University Medical Center
Ranked #20 in Cancer

Ohio State University Hospital

James Cancer Hospital and Solove Research Institute
Ranked #20 in Cancer

Education & Medical Training

Brigham and Women's Hospital
Residency, Internal Medicine, 1983–1986

Dana - Farber Cancer Institute
Fellowship, Medical Oncology, 1986–1989

Stanford University School of Medicine
Class of 1983

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

OH State Medical License
Active through 2013

Awards, Honors & Recognition

Fellow (FACP), American College of Physicians
1998

Elected Member, The American Society for Clinical Investigation
1998

Publications & Presentations

Role of Cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.
Thorne, A. H.,Meisen, W. H.,Russell, L.,Yoo, J. Y.,Bolyard, C. M.,Lathia, J. D.,Rich, J.,Puduvalli, V. K.,Mao, H.,Yu, J.,Caligiuri, M. A.,Tridandapani, S.,Kaur, B.

The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells.
Hughes, T.,Briercheck, E. L.,Freud, A. G.,Trotta, R.,McClory, S.,Scoville, S. D.,Keller, K.,Deng, Y.,Cole, J.,Harrison, N.,Mao, C.,Zhang, J.,Benson, D. M.,Yu, J.,Caligiuri, M. A.

Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic, anti-tumor effects.
Yoo, J. Y.,Hurwitz, B. S.,Bolyard, C.,Yu, J. G.,Zhang, J.,Selvendiran, K.,Rath, K. S.,He, S.,Bailey, Z.,Eaves, D.,Cripe, T. P.,Parris, D. S.,Caligiuri, M. A.,Yu, J.,Old, M.,Kaur, B.

See all 176 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Multiplan PHCS PPO
  • Providence Health System Personal Option
  • Providence Health System Preferred PPO
  • United Healthcare - Direct Options PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • Cofinity PPO
  • Coventry Florida - Employer Group HMO/Open Access
  • Coventry Florida - Employer Group PPO
  • HealthAmerica HealthAssurance PPO
  • Humana ChoiceCare Network PPO
  • Medical Mutual of Ohio SuperMed Plus
  • Medical Mutual of Ohio SuperMed POS
  • Multiplan PPO
  • ODS Network
  • Regence Oregon - Preferred Provider Network
  • United Healthcare - Direct Choice Plus POS

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Columbus, OH See all Medical Oncologists in Ohio

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.